Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Alnylam Pharmaceuticals, Inc. BOERSE MUENCHEN

Equities

DUL

US02043Q1076

Real-time BOERSE MUENCHEN
Other stock markets
 17:13:25 02/07/2024 BST 		5-day change 1st Jan Change
230.4 EUR +1.05% Intraday chart for Alnylam Pharmaceuticals, Inc. +9.14% +28.81%
06-28 UBS Adjusts Price Target on Alnylam Pharmaceuticals to $288 From $253, Maintains Buy Rating MT
06-27 Stifel Adjusts Price Target on Alnylam Pharmaceuticals to $295 From $215, Maintains Buy Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. News Alnylam Pharmaceuticals, Inc.
  6. Official Publications